These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2266458)

  • 1. Growth fraction in lung tumours determined by Ki67 immunostaining and comparison with AgNOR scores.
    Soomro IN; Whimster WF
    J Pathol; 1990 Nov; 162(3):217-22. PubMed ID: 2266458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and estimation of nucleolar organizer regions in various human lung tumours.
    Soomro I; Patel N; Whimster WF
    Pathol Res Pract; 1991 Jan; 187(1):68-72. PubMed ID: 1709285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of DNA ploidy and proliferation rate in lung tumours by bromodeoxyuridine labelling index, S-phase fraction and AgNOR technique.
    Gasińska A; Biesaga B; Kołodziejski L; Słonina D
    Pol J Pathol; 1996; 47(4):201-7. PubMed ID: 9097713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative activity is a significant prognostic factor in male breast carcinoma.
    Pich A; Margaria E; Chiusa L
    Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
    Zhao T; Zhang YL; Li CD
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
    Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
    Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
    Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
    Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
    Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
    Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.
    Yu CC; Fletcher CD; Newman PL; Goodlad JR; Burton JC; Levison DA
    J Pathol; 1992 Feb; 166(2):147-52. PubMed ID: 1348532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
    Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
    J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
    Derenzini M; Trerè D
    Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleolar organizer regions in the fine needle aspirates of lung tumours.
    Ascoli V; Barsotti P; Facciolo F; Nardi F; Marinozzi V
    Cytopathology; 1990; 1(5):277-86. PubMed ID: 1714309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basaloid squamous carcinoma of the oral cavity: report of 2 cases and study of AgNOR, PCNA, p53, and MMP expression.
    Coletta RD; Cotrim P; Vargas PA; Villalba H; Pires FR; de Moraes M; de Almeida OP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):563-9. PubMed ID: 11346736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
    Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
    Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo bromodeoxyuridine labelling index, AgNOR protein expression and DNA content in human tumours.
    Trerè D; Ceccarelli C; Danova M; Derenzini M
    Eur J Histochem; 1996; 40(1):17-26. PubMed ID: 8741096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar organizer regions and Ki-67 immunostaining in ductal breast cancer: a comparative study.
    Canepa M; Gambini C; Sementa AR; Borgiani L; Rovida S
    Pathologica; 1990; 82(1078):125-32. PubMed ID: 2168032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AgNOR area in interphase nuclei of human tumours correlates with the proliferative activity evaluated by bromodeoxyuridine labelling and Ki-67 immunostaining.
    Trerè D; Farabegoli F; Cancellieri A; Ceccarelli C; Eusebi V; Derenzini M
    J Pathol; 1991 Sep; 165(1):53-9. PubMed ID: 1955936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
    Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.